vTv Therapeutics Inc. (VTVT)

AI Score

Unlock

16.93

-0.57 (-3.26%)

At close: Apr 03, 2025, 3:57 PM

16.77

-0.92%

After-hours: Apr 03, 2025, 04:16 PM EDT

vTv Therapeutics Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Revenue	1.02M	n/a	2.02M	4M	6.41M	2.76M	12.43M	291K	634K	519K	1.55M	976K
Cost of Revenue	n/a	13.6M	92K	89K	11.02M	15.12M	23.04M	39.64M	45.75M	29.58M	18.73M	25.43M
Gross Profit	1.02M	-13.6M	1.93M	3.92M	-4.6M	-12.36M	-10.6M	-39.35M	-45.11M	-29.07M	-17.18M	-24.46M
Operating Income	-24.18M	-25.5M	-22.54M	-21.66M	-11.85M	-20.89M	-19.82M	-50.68M	-55.02M	-38.14M	-28.9M	-35.83M
Interest Income	1.56M	472K	352K	1K	12K	53K	61K	117K	87K	n/a	n/a	n/a
Pretax Income	-18.36M	-25.97M	-24.87M	-17.62M	-12.8M	-21.84M	-23.64M	-53.85M	-55.35M	-41.11M	-36.1M	-48.2M
Net Income	-18.46M	-20.25M	-25.07M	-17.73M	-8.83M	-21.94M	-7.91M	-16.14M	-16.35M	-27.5M	-36.1M	-48.2M
Selling & General & Admin	13.65M	11.91M	12.2M	12.34M	7.25M	8.54M	9.22M	11.33M	9.91M	9.08M	11.72M	11.38M
Research & Development	11.55M	13.51M	12.36M	13.32M	11.02M	15.12M	23.04M	39.64M	45.75M	29.58M	18.73M	25.43M
Other Expenses	n/a	-13.51M	-2.67M	4.06M	-270K	828K	-592K	-190K	-22K	-2.96M	-1.13M	-534K
Operating Expenses	25.2M	11.91M	24.56M	25.67M	18.27M	23.66M	32.26M	50.97M	55.65M	38.66M	30.45M	36.81M
Interest Expense	n/a	13K	15K	12K	692K	1.83M	3.29M	3.09M	398K	1.74M	6.01M	11.82M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	25.2M	25.5M	24.56M	25.67M	18.27M	23.66M	32.26M	50.97M	55.65M	38.66M	30.45M	36.81M
Income Tax Expense	100K	n/a	200K	115K	-3.98M	100K	200K	800K	-39M	-14.11M	4.88M	11.29M
Shares Outstanding (Basic)	5.77M	2.08M	1.92M	1.57M	1.18M	757.3K	311.23K	242.33K	238.64K	206.91K	207.63K	205.49K
Shares Outstanding (Diluted)	5.77M	2.08M	1.92M	1.57M	1.18M	757.3K	311.23K	242.33K	238.64K	206.91K	207.63K	205.49K
EPS (Basic)	-3.2	-9.71	-13.06	-11.32	-7.49	-28.97	-25.42	-66.62	-68.52	-132.9	-173.87	-234.57
EPS (Diluted)	-3.2	-9.71	-13.06	-11.32	-7.49	-28.97	-25.42	-66.62	-68.52	-132.9	-173.87	-234.57
EBITDA	-22.52M	-25.41M	-24.77M	-17.52M	-12.02M	-19.97M	-20.14M	-50.56M	-54.69M	-38.87M	-29.23M	-35.3M
EBIT	-22.61M	-25.5M	-24.86M	-17.6M	-12.11M	-20.01M	-20.36M	-50.76M	-54.95M	-39.33M	-30.09M	-36.38M
Depreciation & Amortization	89K	90K	92K	89K	94K	39K	218K	197K	265K	501K	864K	1.09M